Insider Selling: ASP Isotopes (NASDAQ:ASPI) CFO Sells $47,807.70 in Stock

ASP Isotopes Inc. (NASDAQ:ASPI) CFO Heather Kiessling sold 21,830 shares of the business’s stock in a transaction on Friday, October 16th. The shares were sold at an average price of $2.19, for a total transaction of $47,807.70. Following the sale, the chief financial officer directly owned 1,504,422 shares in the company, valued at $3,294,684.18. The trade was a 1.43% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

ASP Isotopes Trading Down 6.7%

NASDAQ:ASPI opened at $1.95 on Friday. ASP Isotopes Inc. has a 1 year low of $1.89 and a 1 year high of $11.22. The stock’s fifty day moving average price is $3.17 and its two-hundred day moving average price is $4.65. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.87 and a quick ratio of 3.85. The company has a market cap of $298.95 million, a P/E ratio of -1.48 and a beta of 3.69.

ASP Isotopes (NASDAQ:ASPI) last announced its quarterly earnings results on Friday, August 14th. The company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.17) by ($0.11). The company had revenue of $5.12 million during the quarter, compared to analysts’ expectations of $4.47 million. ASP Isotopes had a negative net margin of 427.98% and a negative return on equity of 64.99%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on ASPI shares. Wall Street Zen upgraded ASP Isotopes from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, September 21st. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $13.00.

Institutional Investors Weigh In On ASP Isotopes

Several large investors have recently bought and sold shares of the business. Bank of America Corp DE purchased a new position in shares of ASP Isotopes during the second quarter valued at approximately $4,410,000. BlackRock Inc. bought a new stake in ASP Isotopes during the second quarter valued at about $57,331,000. Bank of New York Mellon Corp purchased a new stake in ASP Isotopes in the 2nd quarter worth approximately $2,220,000. Man Group plc bought a new position in shares of ASP Isotopes in the second quarter worth approximately $5,153,000. Finally, AWM Investment Company Inc. bought a new position in shares of ASP Isotopes in the second quarter worth approximately $9,837,000. 16.80% of the stock is currently owned by institutional investors.

About ASP Isotopes

ASP Isotopes Inc is a materials and technology company developing isotope-enrichment processes for use in the medical, semiconductor and nuclear-energy industries. Its primary technology is the Aerodynamic Separation Process, a proprietary method designed to separate isotopes based on differences in molecular mass and aerodynamic behavior.

The company is pursuing the production of enriched isotopes, including materials intended for applications such as semiconductor manufacturing, medical diagnostics and treatment, advanced nuclear fuels, and other industrial and scientific uses.